We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Bayer AG | TG:BAYN | Tradegate | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.495 | 1.76% | 28.55 | 28.53 | 28.57 | 28.65 | 28.035 | 28.05 | 317,947 | 22:50:04 |
From May 2019 to May 2024
By Pietro Lombardi
Bayer AG's impact-investment arm is leading a $17 million series B financing round in U.S. biotech company Azitra Inc.
Leaps by Bayer is investing $8 million in the clinical-stage medical dermatology biotech company, it said Thursday.
"The partnership will focus on developing cutting-edge skin products using engineered and wild-type bacteria for biotherapeutic, over-the-counter (OTC) and cosmetic applications leveraging Azitra's technology platform for both live therapeutic products (LBPs) and consumer programs," it said.
Write to Pietro Lombardi at pietro.lombardi@dowjones.com; @pietrolombard10
(END) Dow Jones Newswires
October 15, 2020 07:40 ET (11:40 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
1 Year Bayer Chart |
1 Month Bayer Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
